IDH1/IDH2 but Not TP53 Mutations Predict Prognosis in Bulgarian Glioblastoma Patients

Figure 1

Kaplan-Meier plots of glioma patients showing the association of the following factors with overall survival: (a) IDH1/IDH2 mutations, (b) TP53 mutations, (c) age, (d) primary versus secondary GBM, (e) KPS, and (f) IDH1 rs11554137.

(a)

(b)

(c)

(d)

(e)

(f)